Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugs.
The introduction of 5-HT3 antagonists, such as ondansetron, as antiemetic agents has transformed the management of patients receiving chemotherapy or radiation therapy. Studies in animal models with NK1 antagonists suggest that these represent a new class of antiemetic agents having a broader spectr...
Main Authors: | Bountra, C, Gale, J, Gardner, C, Jordan, C, Kilpatrick, G, Twissell, D, Ward, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1996
|
Similar Items
-
The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
by: Gardner, C, et al.
Published: (1995) -
ANTIEMETIC ACTIVITY OF NEUROKININ NK1 RECEPTOR ANTAGONISTS IS MEDIATED CENTRALLY IN THE FERRET
by: Gardner, C, et al.
Published: (1994) -
Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets.
by: Bountra, C, et al.
Published: (1993) -
The vomiting reflex and the role of 5-HT3 receptors.
by: Freeman, A, et al.
Published: (1993) -
Nasty shock after an anti-emetic.
by: Maxwell, P, et al.
Published: (2001)